Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Syndrome and Risk of Gastrointestinal Cancers: An Investigation Using Large-scale Molecular Data
Joseph A. Rothwell, Mazda Jenab, Mojgan Karimi, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 6, pp. e1338-e1352
Open Access | Times Cited: 22

Showing 22 citing articles:

Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, et al.
Metabolism (2024) Vol. 160, pp. 156014-156014
Closed Access | Times Cited: 11
Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis
Lei Zhong, Jifeng Liu, Shuo Liu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 18
Association between Surrogate Markers of Insulin Resistance and the Incidence of Colorectal Cancer in Korea: A Nationwide Population-Based Study
Minkook Son, Sang Yi Moon, Myeongseok Koh, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1628-1628
Open Access | Times Cited: 7
The cellular and molecular targets of natural products against metabolic disorders: a translational approach to reach the bedside
Xiaofei Shen, Hongling Yang, Yang Yang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 5
Utility of Polygenic Risk Scores (PRSs) in Predicting Pancreatic Cancer: A Systematic Review and Meta-Analysis of Common-Variant and Mixed Scores with Insights into Rare Variant Analysis
Georgios‐Ioannis Verras, Zaed Hamady, Andrew Collins, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 241-241
Open Access
Developmental Trends of Metabolic Syndrome in the Past Two Decades: A Narrative Review
Ahmad A. Obeidat, Mousa Numan Ahmad, Mai Adil Ghabashi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2402-2402
Open Access
The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy
Elena Crecca, Gianfranco Di Giuseppe, C Camplone, et al.
Pharmacology & Therapeutics (2025), pp. 108847-108847
Closed Access
Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancers
Scott McHenry, Xiaoyu Zong, Mengyao Shi, et al.
Hepatology Communications (2022) Vol. 6, Iss. 12, pp. 3299-3310
Open Access | Times Cited: 14
The Relationship between Surrogate Markers of Insulin Resistance and Occurrence of Colorectal Adenoma in Individuals under 50 Years Old: A Single-Center Retrospective Cross-Sectional Study
Chi Hyeon Choi, Sang Yi Moon, Jong Yoon Lee
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 971-971
Open Access | Times Cited: 2
Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma
Norberto C. Chávez‐Tapia, Sofía Murúa-Beltrán Gall, Ana Luisa Ordóñez-Vázquez, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 583-593
Open Access | Times Cited: 10
A comparison of machine learning models and Cox proportional hazards models regarding their ability to predict the risk of gastrointestinal cancer based on metabolic syndrome and its components
Tao Thi Tran, Jeonghee Lee, Madhawa Gunathilake, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Metabolic Syndrome and Risk of Amyotrophic Lateral Sclerosis: Insights from a Large‐Scale Prospective Study
Junwei Zhang, Wen Cao, Jiali Xie, et al.
Annals of Neurology (2024) Vol. 96, Iss. 4, pp. 788-801
Closed Access | Times Cited: 1
Upregulation of HCFC1 expression promoted hepatocellular carcinoma progression through inhibiting cell cycle arrest and correlated with immune infiltration
Huaxiang Wang, Meng Yu, Chengkai Yang, et al.
Journal of Cancer (2023) Vol. 14, Iss. 8, pp. 1381-1397
Open Access | Times Cited: 4
Developmental Trends of Metabolic Syndrome in the Past Two Decades: A Review
Ahmad A. Obeidat, Mai Adil Ghabashi, Awfa Y. Alazzeh, et al.
(2024)
Open Access | Times Cited: 1
Association between four insulin resistance surrogates and the risk of esophageal cancer: a prospective cohort study using the UK Biobank
Chuang Yang, Wenke Cheng, Patrick Sven Plum, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 8
Open Access | Times Cited: 1
Establishment of a 7-gene expression panel to improve the prognosis classification of gastric cancer patients
Mariana Belén Velásquez Sotomayor, Anthony Vladimir Campos Segura, R. Montalva, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
Do Polygenic Risk Scores Add to Clinical Data in Predicting Pancreatic Cancer? A Scoping Review
Louise Wang, Alyssa Grimshaw, Catherine Mezzacappa, et al.
Cancer Epidemiology Biomarkers & Prevention (2023) Vol. 32, Iss. 11, pp. 1490-1497
Open Access | Times Cited: 1
Patterns of the lymph node metastasis and the influencing factors in esophagogastric junction cancers
Zhang Dan, Qiong Nan
Asian Journal of Surgery (2023) Vol. 46, Iss. 9, pp. 3512-3519
Open Access | Times Cited: 1
Targeted Metabolomics Revealed a Sex-Dependent Signature for Metabolic Syndrome in the Mexican Population
Berenice Palacios‐González, Guadalupe León-Reyes, Berenice Rivera‐Paredez, et al.
Nutrients (2022) Vol. 14, Iss. 18, pp. 3678-3678
Open Access | Times Cited: 2
Metabolisches Syndrom und gastrointestinale Krebsvorsorge
Hans Scherübl
Zeitschrift für Gastroenterologie (2022) Vol. 61, Iss. 10, pp. 1394-1400
Closed Access | Times Cited: 2
Acute Pancreatitis Increases the Risk of Gastrointestinal Cancer in Type 2 Diabetic Patients: A Korean Nationwide Cohort Study
Jin Ho Choi, Woo Hyun Paik, Dong Kee Jang, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5696-5696
Open Access | Times Cited: 2
Changes in Metabolic Syndrome and Its Implications on the Risk and Racial/Ethnic Disparities of Pancreatic Cancer
Brian Huang, Veronica Wendy Setiawan
Gastroenterology (2021) Vol. 162, Iss. 2, pp. 392-394
Closed Access | Times Cited: 2
RHBDF2 is correlated with immune infiltrates in hepatocellular carcinoma and may have potential as a biomarker
Hanjuan Gong, Hailun Xie, Zhimin Huangfu, et al.
FEBS Open Bio (2023) Vol. 13, Iss. 5, pp. 881-897
Open Access
Page 1

Scroll to top